{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Muller AK"],"funding":["Agence Nationale de la Recherche","Rising Tide Foundation","Israel Science Foundation","Fondation pour la Recherche Médicale","Swiss Society of Friends of the Weizmann Institute"],"pagination":["e2105696"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8948556"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["9(9)"],"pubmed_abstract":["Macrophage infiltration in mammary tumors is associated with enhanced tumor progression, metastasis, and poor clinical outcome, and considered as target for therapeutic intervention. By using different genetic mouse models, the authors show that ablation of the tyrosine kinase PYK2, either in breast cancer cells, only in the tumor microenvironment, or in both, markedly reduces the number of infiltrating tumor macrophages and concomitantly inhibits tumor angiogenesis and tumor growth. Strikingly, PYK2 ablation only in macrophages is sufficient to induce similar effects. These phenotypic changes are associated with reduced monocyte recruitment and a substantial decrease in tumor-associated macrophages (TAMs). Mechanistically, the authors show that PYK2 mediates mutual communication between b"],"journal":["Advanced science (Weinheim, Baden-Wurttemberg, Germany)"],"pubmed_title":["Mouse Modeling Dissecting Macrophage-Breast Cancer Communication Uncovered Roles of PYK2 in Macrophage Recruitment and Breast Tumorigenesis."],"pmcid":["PMC8948556"],"funding_grant_id":["1530/17","FRM‐EQU201903007844","ANR‐19‐CE16‐0020","ANR-19-CE16-0020","FRM-EQU201903007844"],"pubmed_authors":["Kohler UA","Vinik Y","Trzebanski S","Maraver A","Muller AK","Girault JA","Ben-Chetrit N","Jung S","Raj HM","Lev S"],"additional_accession":[]},"is_claimable":false,"name":"Mouse Modeling Dissecting Macrophage-Breast Cancer Communication Uncovered Roles of PYK2 in Macrophage Recruitment and Breast Tumorigenesis.","description":"Macrophage infiltration in mammary tumors is associated with enhanced tumor progression, metastasis, and poor clinical outcome, and considered as target for therapeutic intervention. By using different genetic mouse models, the authors show that ablation of the tyrosine kinase PYK2, either in breast cancer cells, only in the tumor microenvironment, or in both, markedly reduces the number of infiltrating tumor macrophages and concomitantly inhibits tumor angiogenesis and tumor growth. Strikingly, PYK2 ablation only in macrophages is sufficient to induce similar effects. These phenotypic changes are associated with reduced monocyte recruitment and a substantial decrease in tumor-associated macrophages (TAMs). Mechanistically, the authors show that PYK2 mediates mutual communication between b","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Mar","modification":"2026-05-31T17:59:51.865Z","creation":"2024-10-18T05:33:56.804Z"},"accession":"S-EPMC8948556","cross_references":{"pubmed":["35092356"],"doi":["10.1002/advs.202105696"]}}